RxDoctor Payments Data

Richard Reutter

Adolescent Medicine · Long Branch, NJNPI 1225089923

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $3,816 of the $6,291 with a category attached, or 60.7%. 16 manufacturers reported payments, led by Adlon Therapeutics L.p. at 31.6% of the total. 2025 is the largest year on record at $2,371, 7.3 times the $324 reported in 2019. Among adolescent medicine clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,291in general payments, 2019–2025

Across 249 payments — averaging $25.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Adlon Therapeutics L.p.$2K
  • Purdue Pharma L.p.$2K
  • Supernus Pharmaceuticals, Inc.$684
  • Tris Pharma Inc$367
  • Corium, LLC$296
  • Neos Therapeutics, LP$279
  • plus $768 from 10 others

What the payments were for

  • Consulting fees$3,81661%
  • Food & beverage$2,46839%
  • Education$70%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,291 in reported general payments places this provider in the 95th percentile of 156 adolescent medicine providers in New Jersey.

See all adolescent medicine providers in New Jersey

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban12$7,391
VyvanseLisdexamfetamine Dimesylate11$4,332
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine34$1,641
Aripiprazole11$1,100
Levetiracetam16$709
Bupropion XlBupropion Hcl15$691
Ibuprofen23$367
Duloxetine Hcl13$219
Gabapentin15$186
NortrelNorethindrone-Ethin. Estradiol12$123
Pantoprazole Sodium22$106
Alprazolam27$88
Lorazepam16$67
Pravastatin Sodium12$61
Lovastatin14$56

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$168$4,33211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 156 adolescent medicine providers in New Jersey.

Other adolescent medicine in Long Branch

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →